Schrodinger
Data as of .
Company facts
-
Founded
1990
-
Headquarters
United States (New York, NY)
Drug discovery partners
1 pharma. Pharma here means a company with approved products and roughly $1B or more in annual revenue.
-
Novartis Pharma
Multi-target collaboration and software license,
$150M upfront ($2.42B total potential)
Drugs on the board
- Zasocitinib (TAK-279, TYK2 inhibitor)
Phase 3 registry
Plaque psoriasis
- SGR-1505 (MALT1 inhibitor)
Phase 1 registry
Mature B-cell neoplasms
- SGR-3515 (WEE1 inhibitor)
Phase 1 registry
Advanced solid tumors
Recent news
-
Collaboration and software agreement with Bristol Myers Squibb to deploy its AI co-scientist Bunsen
-
Reports first quarter 2026 financial results
-
Reports fourth quarter and full-year 2025 financial results
-
Partners with Lilly to make the TuneLab platform available in LiveDesign
Confirmed means the company, a partner or a filing said it. Reported means a third party said it. This section sits outside the Pharma AI Tracker.
Spot an error? Tell me and I'll fix it.